Tardive dyskinesia is a serious and disabling movement disorder that affects individuals treated with antipsychotic agents for a variety of mental health conditions. Though prevention and treatment primarily focus on stopping or changing the offending antipsychotic agent, for some individuals there are no other effective treatment options, and symptoms can persist after discontinuing or changing antipsychotic therapy.
Interventions of Interest:
- Valbenazine (IngrezzaTM, Neurocrine Biosciences, Inc)
- Deutetrabenazine (AustedoTM, Teva)
- Tetrabenazine (Xenazine®)
Date of Review: December 2017